Abbott’s $21Bn Buyout Of Exact Sciences Paves Way To Fast-Growing Cancer Screening Market

 
• By Marion Webb
  
Abbott aquired cancer diagnostics screening company Exact Sciences for $21bn, the largest such deal in the diagnostics business, said Abbott CEO Robert Ford.

More from Deals

More from Business